Effect of hapten plus antihapten-tumor serum treatment on established rat fibrosarcoma.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000008:administration & dosage*; D000918:Antibody Specificity; D006241:Haptens / Q000008:administration & dosage* / Q000276:immunology; D007116:Immunization, Passive; D007167:Immunotherapy; D008297:Male; D008558:Melphalan / Q000276:immunology*; D011817:Rabbits; D051381:Rats; D011917:Rats, Inbred Lew; D012513:Sarcoma, Experimental / Q000276:immunology / Q000628:therapy*; D012882:Skin Tests; D013045:Species Specificity
D000912:Antibodies, Neoplasm; D006241:Haptens; D008558:Melphalan